Multimedia Tools and Applications· 2026Q1
TomoMamba: a two-stage model with state-space cross-slice propagation for breast cancer diagnosis in digital breast tomosynthesis
- 0citations
- Q1SCImago
- 2026year
Short summary
TomoMamba, a two-stage deep learning framework, achieves a 0.93 AUC for breast cancer diagnosis in digital breast tomosynthesis (DBT) by processing slices with state-space models that propagate features along the depth axis, unlike prior methods that treated slices independently.
AI-generated from the title and abstract; the full text is not read.
Key points
- TomoMamba is a two-stage deep learning framework for DBT breast cancer diagnosis.
- It uses state-space models (Mamba) to propagate features along the depth axis, capturing inter-slice continuity.
- The first stage achieves a breast-level AUC of 0.97 for normal/suspicious triage.
- The full cascade model reaches a breast-level AUC of 0.93 on the BCS-DBT dataset.
- The gated cross-slice residual component was critical, with its removal causing a significant AUC drop (0.25).
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Digital breast tomosynthesis (DBT) provides volumetric image stacks that improve lesion conspicuity compared with two-dimensional (2D) mammography, yet most automated methods process slices independently and discard the depth-wise continuity that underpins this advantage. We introduce TomoMamba, a two-stage deep learning framework for DBT screening and diagnosis. A dual-branch 2.5D network with multi-view fusion first triages each breast study as normal or suspicious, reaching a breast-level area under the receiver operating characteristic curve (AUC) of 0.97. Selective state-space (Mamba) models then propagate features along the depth axis at each spatial position through input-dependent state transitions; lesions are localized by an anchor-free CenterNet detector and classified from features cropped at the detected centers. On the public BCS-DBT dataset the cascade reaches a breast-level AUC of 0.93 (95% CI 0.85–0.99) on validation and 0.92 (95% CI 0.86–0.97) on the held-out test partition. On validation it loses two of 20 cancers at screening while forwarding 14% of breasts, so this cascade figure reflects the screening stage rather than benign-versus-cancer discrimination. In isolation, Stage 2 attains a patient-level AUC of 0.80 on validation and 0.62 on test, with lesion detection of 72.0% and 62.5% respectively; as the test classification interval spans chance, we present lesion localization as Stage 2’s demonstrated contribution. The gated cross-slice residual is the only component whose removal produces a significant change (0.25 AUC, $$p = 0.009$$ ). To the best of the authors’ knowledge, this is the first application of selective state-space models to inter-slice feature propagation in DBT.
The authors' abstract, as published at the source. Multimedia Tools and Applications, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pulmonary and Respiratory Medicine
Pulmonary and Respiratory MedicineMedicine